Checkpoint inhibitor pioneer James P. Allison, who won the 2018 Nobel Prize in Medicine, will helm a new research and innovation hub at The University of Texas MD Anderson Cancer Center that is focused on developing new immunotherapy breakthroughs in oncology.
Virologist Luc Montagnier passed away, French news agency AFP reported on February 10. Montagnier won a Nobel Prize for his part in discovering the human immunodeficiency virus (HIV) that causes AIDS,
American scientists David Julius and Ardem Patapoutian won the 2021 Nobel Prize for Medicine on Oct. 4 for the discovery of receptors in the skin that sense temperature and touch and could pave the way for new pain-killers.
Three researchers jointly received the Nobel Prize for Physiology or Medicine for their work in understanding how oxygen levels affect cellular metabolism and physiological function.
Rare Cancer Treatments and the Power of Checkpoint Inhibitors Among Hot Topics at ASCO
American Society of Clinical Oncology (ASCO), Blockbusters, Cancer, Checkpoint Inhibitors, Clinical Studies, Clinical Trials, Data, Desmoid Tumors, Endocrine Therapy, Gastroenteropancreatic neuroendocrine tumors, Lung Cancer, Nobel Prize, Nobel Prize in Physiology or Medicine, Orphan Diseases, PD-L1 Inhibitor, PD-L1 protein, PIK3CA mutations, R&D, Rare Cancers, Rare Sarcomas, Tenosynovial Giant Cell Tumor (TGCT)With the books closed on another ASCO meeting, it’s clear to see that checkpoint inhibitors keep showing a promise.